Thank you, Dave, and good morning, everyone. Revenue for the 2025 was $959,000,000, up 51% or $325,000,000 from the 2025, driven by $388,000,000 of MRC Global contribution from the close date of November 6 through the year-end 2025, referred to as the stub period. On a full-year basis, total 2025 revenue was $2,800,000,000, up $447,000,000, or 19%, from 2024. With and without the contribution from MRC Global, this marks DNOW's fifth consecutive year of growth. Adjusted EBITDA, or EBITDA, for the fourth quarter was $61,000,000, or 6.4% of revenue. On a full-year basis, total 2025 EBITDA was $209,000,000, or 7.4% of revenue. U.S. revenue for the 2025 totaled $765,000,000, with MRC Global contributing $298,000,000 in revenue during the stub period. In the U.S., legacy DNOW fourth quarter revenue was $47,000,000, down approximately 10% sequentially. And when looking at MRC Global U.S. activity in the period, it was down similarly, as all sectors historically contract in the fourth quarter with seasonality. Now moving to Canada. Revenue was $51,000,000 for the fourth quarter, down $2,000,000, or 4%, sequentially. For the full year 2025, Canadian revenue was $200,000,000. Although revenue growth faced challenges from low commodity prices, tariff uncertainties, and customer consolidations, our Canadian operations protected margins by exercising rigorous cost management, as customer budgets recalibrate and measures are made for improved profitability. For consolidated DNOW International, revenue was $143,000,000 in the fourth quarter and $312,000,000 for the full year, with approximately $90,000,000 contributed by MRC Global in the stub period. For the legacy DNOW International segment, fourth quarter revenue was $53,000,000, down $1,000,000 sequentially. For the full year 2025, legacy DNOW International revenue was $222,000,000, down 7.5% on a year-over-year basis, primarily due to a combination of fewer projects and the exit of certain countries in our previously discussed cost restructuring activities and service location optimization to improve long-term profitability. In conjunction with the merger of MRC Global during 2025, legacy DNOW changed its inventory valuation method for U.S. inventories from the moving average cost method to the last-in, first-out, or LIFO, method. This change was applied retrospectively beginning in the fiscal year 2023, and the financials will reflect the revised figures where appropriate. The company determined that LIFO is preferable under ASC 250 because it better reflects the current cost of inventory and cost of goods sold, given the commodity-like nature of DNOW's products and the frequent price fluctuations driven by pricing pressure, global supply dynamics, tariffs, and inflation. LIFO inventory benefits or charges are adjusted in the non-GAAP reconciliation tables to arrive at adjusted gross profit, net income, EPS, and EBITDA. Cost of products in the fourth quarter includes $135,000,000 of acquisition-related costs from the partial burn-off of inventory that was stepped up to fair value as part of the MRC Global merger purchase accounting, and also includes LIFO charges of $9,000,000 for the fourth quarter and $27,000,000 in the full year 2025. Overall, DNOW adjusted gross profit for the fourth quarter was $217,000,000, or 22.6%, compared to $147,000,000, or 23.2%, in the 2025. The variance in adjusted gross profit percentage is primarily due to the contribution from MRC Global in the 2025. Selling, general and administrative, or SG&A, expense for the quarter was $226,000,000, up $114,000,000 sequentially from the third quarter. Approximately $75,000,000 of the increase is attributable to the partial period activity of MRC Global, paired with approximately $50,000,000 of transaction-related expenses, partially offset by favorable asset sales of approximately $5,000,000 in the quarter. In the fourth quarter, we reported $20,000,000 depreciation and amortization expense, and considering a full period of MRC Global, we anticipate the first quarter depreciation and amortization to be approximately $25,000,000. As part of our previously announced international restructuring activities, in the fourth quarter, the International segment recorded a $12,000,000 non-cash charge related to the liquidation of a foreign entity. This charge reflects the reclassification of cumulative foreign currency translation losses from accumulated other comprehensive income and loss, or CTA, to the P&L in the quarter. This charge is presented within the impairment and other charges line of our income statement. Moving to interest expense for the quarter was $4,000,000. And now to income taxes. In the 2025, DNOW's income tax benefit was $29,000,000, and our effective tax rate, as computed on the face of the income statement, was 16.5%. When reconciling our tax rate in the fourth quarter, standalone and year-to-date, to our projected 27% effective tax rate for 2025, or even to the U.S. statutory rate of 21%, you have to consider that due to the transaction-related costs, both periods are in an overall loss position. In the fourth quarter, we incurred transaction-related costs and foreign currency translation adjustments that are not deductible for tax purposes. The disallowed expenses, losses, erode that expected tax benefit as a percentage of our pretax loss when reconciling the U.S. statutory rate of 21%. Reducing our effective tax rate for the periods reported as 16.5% benefit. A few additional comments on the MRC Global merger. The merger was structured as a tax-free transaction, and as a result, DNOW received a carryover tax basis in all assets and liabilities of the company. The U.S. GAAP purchase accounting rules require DNOW to recognize the deferred tax asset, deferred tax liability for book-tax basis differences on assets that were stepped up to fair value for financial reporting purposes. DNOW also acquired certain legacy tax attributes from MRC Global, including tax loss carryforwards in the U.S. and international. While MRC Global's net operating losses in the U.S. are likely going to be subject to limitation going forward, DNOW does not expect any limitation to have a material impact on its financial results. For modeling purposes, we expect DNOW's effective tax rate to be approximately 26% to 27% for the full year 2026. Net loss in the fourth quarter was $147,000,000 and was unfavorably impacted by the fourth quarter merger-related costs, including approximately $50,000,000 of transaction-related costs, $12,000,000 in CTA reclassification charges, and $135,000,000 in inventory step-up to fair value amortization related to the MRC Global merger. We estimate the remaining $41,000,000 in inventory step-up charges will be recorded in the first quarter. Our adjusted net income for the fourth quarter attributable to DNOW Inc. on an average cost basis, normalizing for LIFO adjustments and other items, was $23,000,000, or $0.15 per fully diluted share, compared to $28,000,000, or $0.26 per fully diluted share, in the third quarter 2025. Moving to liquidity and capital structure. Our balance sheet remains healthy with ample liquidity of $588,000,000, including $424,000,000 in availability on our credit facility and $164,000,000 of cash at the end of the fourth quarter. Our leverage ratio, based on net debt of $247,000,000, was 1.2 times, and our total debt balance was $411,000,000 at year-end 2025. We continue to target deleveraging by year-end while also executing on select M&A and being opportunistic on our share buyback program. Our existing $850,000,000 revolving credit facility extends into November 2028. Accounts receivable was $174,000,000 at the end of the fourth quarter, with days sales outstanding, or DSO, of 83 days, impacted by the incongruent contribution between the full balance sheet of the acquired accounts receivable and only a partial quarter of sales contribution. DSOs for the legacy DNOW business were relatively flat at 63 days in 2025. Inventory was $1,192,000,000 at the end of the fourth quarter, up $833,000,000 from the 2025 based on the contribution from MRC Global, with 4Q annualized turn rates of three times. Accounts payable was $603,000,000 at the end of the fourth quarter, an increase of $348,000,000 from the third quarter, impacted by the acquired payables. And for 2025, working capital excluding cash as a percentage of annualized fourth quarter revenue was 29.7%, which is higher due to the partial period impact of MRC Global revenue compared with the ending balance sheet. Without MRC Global activity and working capital contribution, legacy working capital as a percentage of revenue was approximately 15% to 15.8%, consistent with prior quarters and also represents the average of April 2025. As we look forward to 2026, we model working capital as a percentage of revenue to approach 25%. In 2025, we generated $83,000,000 cash from operating activities and invested $7,000,000 for capital expenditures to support growth initiatives, primarily in process solutions and midstream areas, paired with investments to support MRC Global. On a full-year basis, cash flows provided by operating activities was $155,000,000 with $25,000,000 in capital expenditures. Considering the transaction-related cash charges paid in the fourth quarter, cash flow was negatively impacted by approximately $30,000,000. In the fourth quarter, under our previously approved share repurchase program, we repurchased $10,000,000 of common stock. As of December 31, our cumulative repurchases under our $100,000,000 authorized share repurchase program totaled $37,000,000. I will now turn the call back to David Cherechinsky.